US5094939A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Chemiluminescence assays using stabilized dioxetane derivatives
Assignee: Applied Biosystems LLC
•
Filing: 1989-07-19
•
Granted: 1992-03-10
•
Expires: 2009-07-19
Abstract
Abstract A multi-pH chemiluminescence-based assay method comprising first-stage light production by the activation by cleavage of a phosphatase cleavable dioxetane derivative within a pH range optimal for enzyme catalysis, followed by the second-stage generation of increased light energy from the products of enzyme-catalyzed cleavage of the dioxetane derivative by the adjustment of the pH to a strongly alkaline pH optimal for the generation of light energy. The assay method is suitable for both solution phase and solid state assay formats. Light generation enhancers can be used further to increase the light yield.
Inventors
- 👤 Masahisa Okada
- 👤 Yoshihiro Ashihara
- 👤 Tadashi Ninomiya
- 👤 Akira Yano
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 13:46
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/34; C12Q1/42; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/655; C07F9/6551; C07F9/65512; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q2334/00; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/805
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
180 words
In a method of conducting a chemiluminescence-based assay in an aqueous environment in the presence of a stabilized chemiluminescent dioxetane derivative having as the substrate an enzyme cleavable substituent of the formula: ##STR3## where T is a spiro-linked or non-spiro-linked adamantine moiety, R is a lower alkyl group, Y is an aromatic group, M+ is a proton or a cation, and the phosphate group is enzyme cleavable, wherein the substrate is cleaved by a phosphatase enzyme capable of cleaving the phosphate substituent to generate visible light in the form of a sustained glow which is detectable by a light detection means, and the visible light generated is detected, wherein the improvement comprises (a) cleaving the phosophate ester substituent from the dioxetane by adding said phosphatase to said dioxetane at a pH at which said phosphatase has maximum specific activity and stability, (b) allowing the enzyme-catalyzed cleavage reaction to go to substantial completion and (c) adjusting the pH of the reaction mixture to a strongly alkaline pH optimal for the generation of visible light from the products of the cleavage reaction.
Claim 2
Dependent Claim
180 words
In a method of conducting a chemiluminescence-based assay in an aqueous environment in the presence of a stabilized chemiluminescent dioxetane derivative having as the substrate an enzyme cleavable substituent of the formula: ##STR3## where T is a spiro-linked or non-spiro-linked adamantine moiety, R is a lower alkyl group, Y is an aromatic group, M+ is a proton or a cation, and the phosphate group is enzyme cleavable, wherein the substrate is cleaved by a phosphatase enzyme capable of cleaving the phosphate substituent to generate visible light in the form of a sustained glow which is detectable by a light detection means, and the visible light generated is detected, wherein the improvement comprises (a) cleaving the phosophate ester substituent from the dioxetane by adding said phosphatase to said dioxetane at a pH at which said phosphatase has maximum specific activity and stability, (b) allowing the enzyme-catalyzed cleavage reaction to go to substantial completion and (c) adjusting the pH of the reaction mixture to a strongly alkaline pH optimal for the generation of visible light from the products of the cleavage reaction.
Claim 3
Dependent Claim
26 words
A method of claim 1 wherein the enzyme is an acid phosphatase and pH range for the enzyme-catalyzed step if from about 4 to about 7.
Claim 4
Dependent Claim
27 words
A method of claim 1 wherein the enzyme is an alkaline phosphatase, and the pH range for the enzyme-catalyzed step is from about 7 to about 10.5.
Claim 5
Dependent Claim
11 words
A method of claim 1 which is used in an immunoassay.
Claim 6
Dependent Claim
85 words
A method of claim 1 which is used in a polynucleotide assay comprising reacting a DNA specimen with a hapten-labeled complementary probe DNA, and adding thereto alkaline phosphatase bound to an anti-hapten antibody, allowing said antibody to bind to said hapten-labeled probe, adding said diozetane to said mixture, and allowing said cleaving reaction to go forward as recited in claim 1, wherein cleavage of said dioxetane phosphate by said alkaline phosphatase to produce visible light enables the detection of said polynucleotide by said complimentary probe.
Claim 7
Independent Claim
41 words
A method of any one of claims 1-5 wherein said cleavage reaction is stopped prior to substantial completion by adding to said reaction mixture an enzyme stopping reagent before adjusting the reaction mixture to a pH of at least about 11.
Claim 8
Dependent Claim
30 words
A method of claim 6 wherein the stopping reagent is an enzyme inhibitor selected from the group consisting of a chelator, organic phosphoric acid esters, inorganic acids and mixtures thereof.
Claim 9
Dependent Claim
47 words
A method of any one of claim 1-5 wherein a light-enhancing compound selected from the group consisting of mammalian serum albumin, a polyalkyl quaternary amine, fluorescein, dimethylsulfoxide and mixtures thereof is present after the pH of the reaction mixture has been adjusted to at least about 11.
Claim 10
Dependent Claim
62 words
A method of claim 4 carried out as a solid-phase assay comprising combining, as a reaction mixture, an analyte suspected of comprising an antigen, an antibody to said antigen bound to alkaline phosphatase and a solid to which is bound an antibody to said antigen, washing said solid, and adding thereto said dioxetane, and conducting the process as recited in claim 1.
Claim 11
Dependent Claim
15 words
A method of claim 9 wherein said solid phase is polystyrene, polyfluoroethylene, nylon or polyacetal.
Claim 12
Dependent Claim
44 words
A method of claim 9 wherein a light-enhancing compound selected from the group consisting of mammalian serum albumin, a polyalkyl quaternary amine, fluorescein, dimethylsulfoxide and mixtures thereof is present after the pH of the reaction mixture has been adjusted to at least about 11.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-10 | 1995-09-09 | 1996-03-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-10 | 1999-09-09 | 2000-03-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-10 | 2003-09-09 | 2004-03-10 | $7700.00 | Window Closed / Lapsed |